New-onset guttate psoriasis secondary to COVID-19

Meriem Rouai; Faten Rabhi; Nada Mansouri; Kahena Jaber; Raouf Dhaoui

doi:10.1002/ccr3.4542

New-onset guttate psoriasis secondary to COVID-19

Clin Case Rep. 2021 Jul 28;9(7):e04542. doi: 10.1002/ccr3.4542. eCollection 2021 Jul.

Authors

Meriem Rouai¹, Faten Rabhi¹, Nada Mansouri², Kahena Jaber¹, Raouf Dhaoui¹

Affiliations

¹ Department of Dermatology The Military Hospital of Tunis Tunis Tunisia.
² Department of Pathology The Military Hospital of Tunis Tunis Tunisia.

Abstract

SARS-CoV-2, the virus that causes coronavirus disease 2019 (COVID-19), is associated with flares of psoriasis in patients with well-documented disease. Both viral infection and medications used for treatment, like hydroxychloroquine, were incriminated. Herein, we report the case of a 25-year-old male patient who presented a first-onset guttate psoriasis following a COVID-19 infection. We have not found previous descriptions of de novo guttate psoriasis post-COVID-19.

Keywords: COVID‐19; SARS‐CoV‐2; infection; psoriasis.

Publication types

Case Reports